The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after ...

The ANVISA decision marks the world’s first approval of a chikungunya vaccine in an endemic country. Part of Valneva ... middle-income countries (LMICs). IXCHIQ ® is the world’s first ...

Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.

EMA has maintained current recommendations for IXCHIQ ® for people from 12 to ... for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion 7 PAHO/WHO data: Number of reported ...

ACIP maintained its current recommendation for IXCHIQ ® for persons aged ≥18 years traveling to a country or territory where there is a chikungunya outbreak. Additionally, it may be considered for ...

Ixchiq -- the first preventive ... the vaccine last month for adults traveling to a country or territory where there is a chikungunya outbreak. The recommendation is yet to be signed off by ...

EMA has maintained current recommendations for IXCHIQ ® for people from 12 to 64 years of age. The decision was taken following a plenary meeting of the Pharmacovigilance Risk Assessment ...